{"id":4450,"date":"2016-11-25T17:42:53","date_gmt":"2016-11-25T17:42:53","guid":{"rendered":"https:\/\/sbglaucoma2.websiteseguro.com\/medico\/?p=4450"},"modified":"2016-11-25T17:42:53","modified_gmt":"2016-11-25T17:42:53","slug":"oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states","status":"publish","type":"post","link":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/","title":{"rendered":"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States"},"content":{"rendered":"<h3>Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States<\/h3>\n<div class=\"row-fluid\">\n<div class=\"span6\"><span class=\"tituloDoutorEsq\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2016\/11\/alessandra.png\" alt=\"\" width=\"100\" height=\"120\" class=\"alignleft size-full wp-image-2862\" \/><strong>Alessandra A. Kusabara<\/strong><br \/>Fellow do Servi\u00e7o de Glaucoma, Irmandade da Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo\t<\/p>\n<\/div>\n<div class=\"span6\"><span class=\"tituloDoutorEsq\"><img loading=\"lazy\" decoding=\"async\" class=\"borderLeft alignleft wp-image-839 size-full\"  src=\"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2016\/11\/niro.png\"  width=\"100\" height=\"120\" class=\"alignright size-full wp-image-1065\" \/><strong>Niro Kasahara<\/strong><br \/>Chefe do Servi\u00e7o de Glaucoma, Irmandade da Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo; Professor Adjunto, Faculdade de Ci\u00eancias M\u00e9dicas da Santa Casa de S\u00e3o Paulo<br \/>\n<\/span>\n<\/div>\n<\/div>\n<p>Ref.: <strong>Wang YE, Kakigi C, Barbosa DT, et al. Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States. Ophthalmology 2016;123:729-736. <\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Dentre os fatores de risco conhecidos para o glaucoma, como hist\u00f3ria familiar, idade avan\u00e7ada, ra\u00e7a negra, a press\u00e3o intraocular \u00e9 a \u00fanica modific\u00e1vel e por isso, \u00e9 o alvo das terapias de tratamento. Identificar novos fatores de risco \u00e9 importante para screening precoce da popula\u00e7\u00e3o alvo.<\/p>\n<p>Neste estudo, os autores investigaram a associa\u00e7\u00e3o entre o uso de contraceptivo oral e preval\u00eancia de glaucoma ou hipertens\u00e3o ocular em pacientes acima ou igual a 40 anos de idade nos Estados Unidos.<\/p>\n<p><span class=\"destaqueBgVerdeFloat\"><br \/>\nO resultado foi que pacientes com tr\u00eas ou mais anos de uso de contraceptivo oral tiveram maior risco de glaucoma ou hipertens\u00e3o ocular (OR 1,94).<\/span><\/p>\n<p>O resultado foi que pacientes com tr\u00eas ou mais anos de uso de contraceptivo oral tiveram maior risco de glaucoma ou hipertens\u00e3o ocular (OR 1,94).<\/p>\n<p>Outros fatores associados nesse estudo foram a menarca tardia (> 13 anos), a menopausa precoce, a terapia de reposi\u00e7\u00e3o hormonal e maior n\u00famero de gesta\u00e7\u00f5es (an\u00e1lise univariada); na an\u00e1lise muitivariada, somente a idade da menarca foi associada com glaucoma ou hipertens\u00e3o ocular. Ainda mais, histerectomia, ooforectomia bilateral, c\u00e2ncer de mama, \u00fatero ou ov\u00e1rio em pacientes com pelo menos 3 anos de uso de contraceptivo oral aumentou o risco de glaucoma.<\/p>\n<p>A teoria \u00e9 que o estrog\u00eanio tenha um efeito neuroprotetor, mas n\u00e3o se sabe qual o mecanismo de a\u00e7\u00e3o, nem qual seriam a concentra\u00e7\u00e3o e o modo de administra\u00e7\u00e3o associado com este efeito. O uso de contraceptivo oral causa altera\u00e7\u00e3o no ciclo menstrual e concentra\u00e7\u00f5es hormonais fisiol\u00f3gicas, que pode ser importante na patogenia de doen\u00e7as glaucomatosas. <\/p>\n<p>Entre as limita\u00e7\u00f5es do estudo, est\u00e1 \u00e0 falta de confirma\u00e7\u00e3o diagn\u00f3stica dos pacientes que foram informados a respeito de glaucoma ou hipertens\u00e3o ocular, poucos pacientes realizaram FDT e poucos pacientes apresentavam escava\u00e7\u00e3o > 0,7. Al\u00e9m disso, os contraceptivos n\u00e3o foram avaliados quanto \u00e0 sua composi\u00e7\u00e3o e concentra\u00e7\u00e3o dos horm\u00f4nios.<br \/>\n<span class=\"destaqueBgVerdeFloat\">Portanto, os achados deste estudo, embora ainda necessitem de comprova\u00e7\u00e3o futura, sugerem que o questionamento sobre a sa\u00fade reprodutiva da mulher pode fornecer informa\u00e7\u00f5es relevantes para a identifica\u00e7\u00e3o de fatores de risco para o glaucoma.<\/span><\/p>\n<p>Portanto, os achados deste estudo, embora ainda necessitem de comprova\u00e7\u00e3o futura, sugerem que o questionamento sobre a sa\u00fade reprodutiva da mulher pode fornecer informa\u00e7\u00f5es relevantes para a identifica\u00e7\u00e3o de fatores de risco para o glaucoma.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States Alessandra A. KusabaraFellow do Servi\u00e7o de Glaucoma, Irmandade da Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo Niro KasaharaChefe do Servi\u00e7o de Glaucoma, Irmandade da Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo; Professor Adjunto, Faculdade de Ci\u00eancias M\u00e9dicas da Santa Casa [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_joinchat":[],"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4450","post","type-post","status-publish","format-standard","hentry","category-sem-categoria"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States - SBG - Sociedade Brasileira de Glaucoma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States - SBG - Sociedade Brasileira de Glaucoma\" \/>\n<meta property=\"og:description\" content=\"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States Alessandra A. KusabaraFellow do Servi\u00e7o de Glaucoma, Irmandade da Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo Niro KasaharaChefe do Servi\u00e7o de Glaucoma, Irmandade da Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo; Professor Adjunto, Faculdade de Ci\u00eancias M\u00e9dicas da Santa Casa [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/\" \/>\n<meta property=\"og:site_name\" content=\"SBG - Sociedade Brasileira de Glaucoma\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-25T17:42:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sbglaucoma2.websiteseguro.com\/medico\/wp-content\/uploads\/2016\/11\/alessandra.png\" \/>\n<meta name=\"author\" content=\"Ricardo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ricardo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/\"},\"author\":{\"name\":\"Ricardo\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/#\\\/schema\\\/person\\\/3b5653b1267e6a6d05de21f0ebd8e3c2\"},\"headline\":\"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States\",\"datePublished\":\"2016-11-25T17:42:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/\"},\"wordCount\":519,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbglaucoma.org.br\\\/medico\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/alessandra.png\",\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/\",\"url\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/\",\"name\":\"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States - SBG - Sociedade Brasileira de Glaucoma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbglaucoma.org.br\\\/medico\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/alessandra.png\",\"datePublished\":\"2016-11-25T17:42:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/#\\\/schema\\\/person\\\/3b5653b1267e6a6d05de21f0ebd8e3c2\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sbglaucoma.org.br\\\/medico\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/alessandra.png\",\"contentUrl\":\"https:\\\/\\\/sbglaucoma.org.br\\\/medico\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/alessandra.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/#website\",\"url\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/\",\"name\":\"SBG - Sociedade Brasileira de Glaucoma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/#\\\/schema\\\/person\\\/3b5653b1267e6a6d05de21f0ebd8e3c2\",\"name\":\"Ricardo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g\",\"caption\":\"Ricardo\"},\"url\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/author\\\/ricardo\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States - SBG - Sociedade Brasileira de Glaucoma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/","og_locale":"pt_BR","og_type":"article","og_title":"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States - SBG - Sociedade Brasileira de Glaucoma","og_description":"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States Alessandra A. KusabaraFellow do Servi\u00e7o de Glaucoma, Irmandade da Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo Niro KasaharaChefe do Servi\u00e7o de Glaucoma, Irmandade da Santa Casa de Miseric\u00f3rdia de S\u00e3o Paulo; Professor Adjunto, Faculdade de Ci\u00eancias M\u00e9dicas da Santa Casa [&hellip;]","og_url":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/","og_site_name":"SBG - Sociedade Brasileira de Glaucoma","article_published_time":"2016-11-25T17:42:53+00:00","og_image":[{"url":"https:\/\/sbglaucoma2.websiteseguro.com\/medico\/wp-content\/uploads\/2016\/11\/alessandra.png","type":"","width":"","height":""}],"author":"Ricardo","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Ricardo","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/#article","isPartOf":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/"},"author":{"name":"Ricardo","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/#\/schema\/person\/3b5653b1267e6a6d05de21f0ebd8e3c2"},"headline":"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States","datePublished":"2016-11-25T17:42:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/"},"wordCount":519,"commentCount":0,"image":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2016\/11\/alessandra.png","inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/","url":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/","name":"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States - SBG - Sociedade Brasileira de Glaucoma","isPartOf":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/#primaryimage"},"image":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/#primaryimage"},"thumbnailUrl":"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2016\/11\/alessandra.png","datePublished":"2016-11-25T17:42:53+00:00","author":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/#\/schema\/person\/3b5653b1267e6a6d05de21f0ebd8e3c2"},"breadcrumb":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/#primaryimage","url":"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2016\/11\/alessandra.png","contentUrl":"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2016\/11\/alessandra.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/oral-contraceptive-use-and-prevalence-of-self-reported-glaucoma-or-ocular-hypertension-in-the-united-states\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.sbglaucoma.org.br\/medico\/"},{"@type":"ListItem","position":2,"name":"Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States"}]},{"@type":"WebSite","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/#website","url":"https:\/\/www.sbglaucoma.org.br\/medico\/","name":"SBG - Sociedade Brasileira de Glaucoma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sbglaucoma.org.br\/medico\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/#\/schema\/person\/3b5653b1267e6a6d05de21f0ebd8e3c2","name":"Ricardo","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g","caption":"Ricardo"},"url":"https:\/\/www.sbglaucoma.org.br\/medico\/author\/ricardo\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/posts\/4450","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/comments?post=4450"}],"version-history":[{"count":1,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/posts\/4450\/revisions"}],"predecessor-version":[{"id":4453,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/posts\/4450\/revisions\/4453"}],"wp:attachment":[{"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/media?parent=4450"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/categories?post=4450"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/tags?post=4450"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}